A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has ...
As of Tuesday, a parasite called cyclospora has sickened nearly 7,000 people in 34 states so far this summer. On Monday, ...
An analysis of public comments on a White House proposal to change the way federal contracts and grants are doled out shows ...
Fallout from the end of ACA subsidies, the FDA CBER acting director "on planet Earth," and more health news from Morning ...
A former FDA toxicologist has accused the agency of authorizing Zyn nicotine pouches without fully reviewing their safety ...
Prescription drugs purchased under a controversial government discount program amounted to $100 billion in 2025, a 22.8% ...
This is the year artificial intelligence has emerged in the public square as a full-fledged bogeyman. So this month’s low-key ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA ...
Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...
The U.S. can save lives from excess alcohol use without taking drastic measures. Here are 12 steps that can help.
NEW YORK — Infections from the diarrhea-causing parasite cyclospora are surging, with state-level data suggesting that 2026 is already the nation’s worst year for reported cases. More than 30 states ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — An experimental Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results